Anti-memory loss drugmaker settles deceptive advertising charges
KeyView Labs, which makes the dietary supplement Procera AVH, agreed to pay $1.4 million to settle charges by the Federal Trade Commission that it falsely claimed its product would reverse memory...
Subscription required to view this article.This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: